Title:
【発明の名称】α4β1媒介細胞接着のインヒビター
Document Type and Number:
Japanese Patent JP2003524614
Kind Code:
A
Abstract:
The present invention relates to small molecules according to formula (I) which are potent inhibitors of a alpha 4 beta 1 mediated adhesion to either VCAM or CS-1 and which can be used for treating or preventing alpha 4 beta 1 adhesion mediated conditions in a mammal such as a human.
More Like This:
Inventors:
Bradley Earl Tea Garden
Shi, Ian
Kenji Matsuki
Robert acre seal
PHARMACIA & UPJOHN COMPANY
Steven P. Teinis
Edward W. Thomas
James Earl Bryn
Shi, Ian
Kenji Matsuki
Robert acre seal
PHARMACIA & UPJOHN COMPANY
Steven P. Teinis
Edward W. Thomas
James Earl Bryn
Application Number:
JP2000589501A
Publication Date:
August 19, 2003
Filing Date:
December 20, 1999
Export Citation:
Assignee:
Tanabe Pharmaceutical Co., Ltd.
PHARMACIA&UPJOHN COMPANY
PHARMACIA&UPJOHN COMPANY
International Classes:
A61K31/198; A61K31/22; A61K31/36; A61K31/401; A61K31/44; A61K31/445; A61K31/472; A61K31/5375; A61P1/04; A61P9/10; A61P11/06; A61P17/06; A61P27/02; A61P29/00; A61P37/08; C07C233/87; C07C235/12; C07C235/20; C07C235/74; C07C235/78; C07C235/82; C07C235/84; C07C237/24; C07C237/36; C07C237/42; C07C255/31; C07C275/26; C07C275/42; C07C323/62; C07D207/16; C07D211/60; C07D211/62; C07D213/64; C07D295/04; C07D213/65; C07D213/81; C07D213/82; C07D215/48; C07D217/16; C07D231/14; C07D237/14; C07D277/06; C07D295/215; C07D307/24; C07D307/71; C07D317/58; C07K5/02; C07K5/06; C07K5/065; C07K5/078; C07K5/097; A61K38/00; (IPC1-7): C07C233/87; A61K31/198; A61K31/22; A61K31/36; A61K31/401; A61K31/44; A61K31/445; A61K31/472; A61K31/5375; A61P1/04; A61P9/10; A61P11/06; A61P17/06; A61P27/02; A61P29/00; A61P37/08; C07C235/12; C07C237/36; C07C237/42; C07C323/62; C07D207/16; C07D211/60; C07D213/65; C07D213/82; C07D215/48; C07D217/16; C07D231/14; C07D237/14; C07D277/06; C07D295/04; C07D307/24; C07D307/71; C07D317/58
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)